Cost-effectiveness Analysis of Three Therapeutic Schemes for Sudden Deafness / 中国药房
China Pharmacy
;
(12): 221-222, 2001.
Article
in Chinese
| WPRIM
| ID: wpr-410703
ABSTRACT
OBJECTIVE:
To evaluate three therapeutic schemes for sudden deafness with cost-effectiveness analysis for guiding rational use of drugs.METHODS:
Using pharmacoeconomic cost-effectiveness analysis to evaluate 61 patients with 62ears of sudden deafness treated by Salvia Miltiorrhiza(groups A), Salvia Miltiorrhiza and cerebroprotein hydrolysate(groups B) or cerebroprotein hydrolysate(groups C) .RESULTS:
The effective rates of three groups were 73.9%, 75.0% and 80.0% respectively without significant difference among them(P > 0.05) . The average drug costs for one patient in three groups were 617.89 yuan, 2 651.29 yuan and 2 647.99 yuan respectively. The costs for 1% increase of effective rate in three groups were 8.36 yuan, 35.35 yuan and 33.10 yuan respectively.CONCLUSION:
Salvia Miltiorrhiza scheme is the most rational one for sudden deafness.
Full text:
Available
Index:
WPRIM (Western Pacific)
Type of study:
Health economic evaluation
Language:
Chinese
Journal:
China Pharmacy
Year:
2001
Type:
Article
Similar
MEDLINE
...
LILACS
LIS